8th NHS Oncology Conference: Exploring Innovation and Best Practice

Clinical Diagnostics & Medical Sciences

09:00 am
01 Oct, 2024
15Hatfields Conference Centre, London SE1 8DJ

8th NHS Oncology Conference: Exploring Innovation and Best Practice

Clinical Diagnostics & Medical Sciences

09:00 am
01 Oct, 2024
15Hatfields Conference Centre, London SE1 8DJ

Job titles includes

Programme Director - Cancer Strategy

Health Data Innovation Manager

Director of Cancer and Palliative Care Nursing

Divisional Director of Operations

130
Delegates Registered

Organisations Involved

Barts Health NHS Trust HEE Fund

Guy's and St Thomas' NHS Foundation Trust

Mid and South Essex NHS Foundation Trust

NORTH MIDDLESEX HOSPITAL NHS TRUST

Current Landscape:

One in every two people in the country is diagnosed with cancer at some point in their lives.

The NHS Long Term Plan aims to save thousands more lives each year by dramatically improving how we diagnose and treat cancer. The NHS’ ambition is, that by 2028, an extra 55,000 people each year will survive for 5 years or more following their cancer diagnosis.

The NHS Long Term Plan for Cancer states that ‘where appropriate every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support.’

Importance and Timeliness of the Event:

393,000 people are diagnosed with cancer each year, on average someone in the UK is diagnosed every 90 seconds, with the number increasing every year. There is not a better time than now to act and make changes to these numbers bettering the lives of those living with cancer and bettering our healthcare system.

The Oncology Conference South aims to provide a secure and focused environment for NHS Oncology specialists to listen, learn and engage with peers and sector leaders from across the UK and further afield.

Key Content Streams:

  • Developments in Radiotherapy - As the number of cancers diagnosed in the early stages increases, radiotherapy will play an increasing role in curing them.
  • Proton Beam Therapy - Proton beam therapy is now in routine use in the UK, with recruitment ongoing for clinical trials to define the future benefits of this therapy. Artificial intelligence (AI) and improved computing power are making it faster to plan radiotherapy treatments.
  • Anti-Cancer Drugs - Anti-cancer drugs are improving cure rates and can make many cancers into chronic diseases that people can live with. There is much research into combining new drugs with radiotherapy to increase the options for each patient.  
  • Genetic Mapping - enabling clinical oncologists to prescribe targeted, fully personalised systemic treatments and radiotherapy. By understanding and explaining genomics, the role of AI and the benefits and potential side effects of therapies, we can ensure each patient continues to receive truly personalised treatment that respects their individual beliefs, values and priorities.  

Why Attend:

Our upcoming Oncology Conference South will open the floor to NHS professionals to come and discuss how the NHS is planning to lean on new models of delivery and innovation within the oncology sector. How the NHS plans to lean on new models of delivery and innovation to help manage the current backlogs and improve outcomes on a national scale.

Join us at The Oncology Conference South as we explore these new areas of best practice, network with peers and share insights.

Register now to be a part of this transformative journey and contribute to building a better future for healthcare.

The programme

09:00

Registration and Breakfast

Registration - Open from 9:00 am - Closes at 11:00 am

All delegates must complete their registration process before the 11:00 AM cut-off time. Please arrive in a timely manner to allow for registration and to avoid any inconvenience. Delegates who arrive after the registration deadline will be refused entry to the event.

We appreciate your cooperation in helping us maintain the event's schedule and ensuring that everyone can fully participate in the Oncology Conference. If you have any questions or require assistance, our event staff will be available to assist you with the registration process.

Thank you for your understanding, and we look forward to an insightful and productive event together!

10:00

Chair Opening Address (Confirmed)

Avril Chester
Chief Technology Officer
Royal Pharmaceutical Society

Chair Opening Address (Confirmed)

10:05

Keynote Presentation - Update on the NHS Cancer Programme (Confirmed)

David Fitzgerald
Director – Policy and Strategy, NHS Cancer Programme
NHS England

Synopsis TBC

10:25

The Challenges Faced in Cancer Care Panel Discussion

Professor Tom Crosby
Professor Clinical Oncology and National Cancer Clinical Director for Wales
Velindre University Trust and Wales Cancer Network
Prof Jayant Vaidya
Professor of Surgery and Oncology
University College London
Dr Clare Stephens
Co Clinical Director
North Central London Cancer Alliance
Joanna Fairhurst
Senior Programme Manager for Treatment & Care
West Midlands Cancer Alliance

Within this session we will discuss the challenges faced in the cancer departments and look at the opportunities provided to face these challenges within the cancer community for both patients and clinicians.  

Panellists: 

  • Dr Clare Stephens, Clinical Director of the North Central London Cancer Alliance and local GP (Confirmed)
  • Professor Jayant S Vaidya, Professor of Surgery and Oncology, University College London (Confirmed)
  • Professor Tom Crosby, Professor Clinical Oncology and National Cancer Clinical Director for Wales,Velindre University Trust and Wales Cancer Network (Confirmed) 
  • Joanna Fairhurst, Senior Programme Manager for Treatment & Care, West Midlands Cancer Alliance (Confirmed)

10:55

Case Study - Transforming Cancer Detection Starts in Primary Care: The Impact of an AI-driven Platform on Earlier and Faster Cancer Diagnosis

Dr Bea Bakshi
CEO and Co-Founder
C the Signs
Dr Seema Dadhania
Consultant Clinical Oncologist & Honorary Clinical Senior Lecturer
Imperial College London

Case Study - C the signs

This session will showcase how C the Signs is transforming cancer detection through the use of AI and advanced data analytics.

We will discuss the platform's 99% sensitivity, 94% accuracy in predicting tumour origin, and 99% negative predictive value, which allow for earlier and more accurate diagnosis of cancer.

With over 350,000 cancer risk assessments conducted in the NHS, C the Signs is having a statistically significant impact on cancer detection rates, particularly in hard-to-diagnose cancers.

The session will highlight how AI-driven tools are improving faster diagnostic standards and access to oncology services, paving the way for improved outcomes and survival rates.

11:15

Morning Break

Morning Break

12:15

Chair Morning Reflection (Confirmed)

Avril Chester
Chief Technology Officer
Royal Pharmaceutical Society

Chair Morning Reflection (Confirmed)

12:20

Case Study - Precision Oncology: Datar cancer Genetics UK

Dr Atreyee Saha
Director of Laboratory and Technologies
Datar Cancer Genetics UK

Case Study - Datar Cancer Genetics

Datar Cancer Genetics UK’s comprehensive cancer testing solutions are backed by a wealth of peer-reviewed research. Combining innovative technologies, a focus on quality assurance, and UK-based expertise, we deliver reliable cancer diagnostics solutions across the cancer management spectrum. Beyond a technical overview, this talk will delve into key publications demonstrating the clinical impact of our solutions.

12:40

Fireside Chat with Dr. Gerald Lip on AI Advancements in Breast Screening (Confirmed)

Dr Gerald Lip
Clinical Director, North East of Scotland Breast Screening Service
NHS Grampian

Overview: 

Join us for an enlightening fireside interview with Dr. Gerald Lip, Clinical Director for Breast Screening in Northeast Scotland, as he shares his pioneering work in the integration of artificial intelligence (AI) in oncology care. Dr. Lip, Principal Investigator of the groundbreaking GEMINI prospective evaluation in mammography AI, will delve into the implications of AI-supported diagnostics on breast cancer detection and treatment. 

With a distinguished background in both clinical practice and research, Dr. Lip brings a wealth of expertise to the forefront of innovation in healthcare. He will discuss his recent endeavours, including a comprehensive retrospective research project and a prestigious two-year Innovation Fellowship, aimed at driving the adoption of AI technologies within the NHS.  

As a prominent figure in the field, Dr. Lip's insights extend beyond the laboratory, encompassing educational initiatives, public engagement, and professional advocacy. From his role as vice-chair of the British Society of Breast Radiology to his contributions to the UK Royal College of Radiology Informatics committee, Dr. Lip is at the forefront of shaping the future of oncological care. 

Don't miss this opportunity to gain valuable insights into the intersection of AI and oncology, as Dr. Gerald Lip shares his perspective on the transformative potential of technology in improving patient outcomes and advancing the field of breast cancer screening. 

13:10

Networking and Lunch & FBK Medical Roundtable

Networking and Lunch & FBK Medical Roundtable

14:20

Chair Afternoon Address (Confirmed)

Avril Chester
Chief Technology Officer
Royal Pharmaceutical Society

Chair Afternoon Address (Confirmed)

14:25

Keynote Presentation - Improving breast cancer radiotherapy by giving during surgery (Target-IORT) (Confirmed)

Prof Jayant Vaidya
Professor of Surgery and Oncology
University College London

Synopsis TBC

14:45

Interview Session: How Robust Commissioning has an Impact on Cancer Care (Confirmed)

Lucy McLaughlin
Head of Cancer Commissioning for
NCL Cancer Alliance and NCL ICB

An overview of current areas of focus including our innovative take on a strategic review of fragile cancer services and developing a cancer commissioning strategy.

15:05

Canapés, Drinks and Networking

Canapés, Drinks and Networking

16:05

End of Day

End of Day

Convenzisvents

Your Pass Includes....

  • Access to a leading conference speaker programme
  • Interactive Q&A sessions
  • Fireside interviews
  • Cross-sector best practice
  • Meet the supplier opportunities
  • Hot breakfast & Lunch included
  • Access to post event drinks reception and Street food

Tickets For NHS Senior Managers

We have an invite only option for NHS Senior Managers for our conference, to see if you qualify for a complimentary place please click the button below.

Register your place

Our accreditations

abpco 2021
Manchester Bee
CPD Member
Living Wage Member
Good Employment - Sponsor
Good Employment - Member
Armed Forces Covenant
Tech UK
IHSCM
FSB
Ban The Box
Stockport County
cpdgroup